Browse studies

Find your next paid study

3,226 recruiting studies matching your filters

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

Blue light cystoscopy (BLC) is a diagnostic procedure in bladder cancer where the inside of the bladder is observed with a camera to detect bladder lesions. Un…

Bladder CancerNon-muscle Invasive Bladder Cancer

Estimated

~$10 – $1,125

Actual pay is set by the research site.

PhotocureNCT07144319

Phase 2

Probiotics to Treat HSIL and Reduce Persistent High Risk HPV Infection in Women and Men Living With HIV

This study is focused on treatment of anal high-grade squamous intraepithelial lesions (HSIL) in persons with HIV (PWH), with the ultimate goal of applying the…

HSIL, High Grade Squamous Intraepithelial LesionHPV-Related Squamous Cell CarcinomaAnal HSIL

Estimated

~$75 – $1,800

Actual pay is set by the research site.

University of California, San FranciscoNCT06949800

Phase 1

Phase 1/2 Study of Intravesical MK-3120 in BCG-Naïve or BCG-Exposed High-Risk Non-muscle Invasive Bladder Cancer

Researchers are looking for new ways to treat high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of t…

Bladder CancerUrinary Bladder Neoplasms

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT07222488

Phase 1

An Open-label, Multi-center, Phase I/II Study of GVV858 as a Single Agent and in Combination With Endocrine Therapy in Patients With Advanced Hormone Receptor Positive, HER2- Negative Breast Cancer and Other Advanced Solid Tumors

Phase I: Characterize safety and tolerability of GVV858 as a single agent and in combination with fulvestrant or letrozole. Identify dose range for optimizatio…

Advanced HR+/HER2- Breast CancerAdvanced CCNE1-amplified Solid TumorsMetastatic Castration-resistant Prostate Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT07288359

Phase 1

A Phase 1 Study of Lenalidomide in Combination With EPOCH Chemotherapy for HTLV-Associated Adult T-Cell Leukemia-Lymphoma (ATLL)

This phase I trial studies the side effects and best dose of lenalidomide when given together with usual combination chemotherapy (etoposide, prednisone, vincr…

Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+1 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT04301076

Phase 1

A Phase 1/2 Study of [18F]FPyQCP for PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

This is a multi-center, open-label, single-arm, Phase 1/2 study designed to evaluate the safety, radiation dosimetry, and preliminary diagnostic performance of…

Colorectal CancerEpithelial Ovarian CancerGastric Cancer+2 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Blue Earth DiagnosticsNCT07432633

Observational

Cerebello-cortical Connectivity as an Adaptive Mechanism for Balance Control With Aging

This study will investigate how communication between the cerebellum and cerebral cortex contributes to balance control and adaptation in younger and older adu…

AgingPostural BalanceMotor Adaptation

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MinnesotaNCT07901322

Blinded Reference Set for Multicancer Early Detection Blood Tests

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing …

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+57 more

Phase 2

Phase II Study of Sarilumab With Immune Checkpoint Inhibitor Rechallenge in Patients With Clinically Significant Immune Related Adverse Events (The IRIS Trial: Immune Checkpoint Inhibitor Rechallenge Involving Sarilumab)

The study will enroll patients with history of malignancy treated with immune checkpoint inhibitors (ICI) that have developed a grade 2 or higher immune relate…

Any Advanced Solid Tumors

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07836101

Observational

The Effects of Nicotinamide Riboside Supplementation on Brain NAD+/NADH Ratio and Bioenergetics

The goal of this clinical trial is to learn how nicotinamide riboside (NR), a form of vitamin B3, affects brain energy metabolism in healthy adults. Researcher…

Healthy Adult

Estimated

~$10 – $750

Actual pay is set by the research site.

Massachusetts General HospitalNCT07649161

Phase 2

A Phase 2/3, Randomized Study of Ordastobart (INBRX-106) Plus Pembrolizumab vs Pembrolizumab as First-Line Treatment for Patients With Recurrent or Metastatic HPV-positive Oropharyngeal Squamous Cell Carcinoma Expressing PD-L1 (HexAgon-HN)

This seamless phase 2/3 randomized controlled study will evaluate the efficacy and safety of the hexavalent OX40 agonist antibody ordastobart (INBRX-106) combi…

Head and Neck Squamous Cell Carcinoma (HNSCC)HPV Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Inhibrx Biosciences, IncNCT06295731

Phase 1

Phase 1/1b Study of the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

The primary purpose of this study is to assess the safety and tolerability of lunresertib alone and in combination with RP-3500 or in combination with zedorese…

Advanced Solid Tumor

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Debiopharm International SANCT04855656